
- Windtreetx.com - WINDTREE THERAPEUTICS- Windtree Therapeutics is a biopharmaceutical company focused on oncology and cardiovascular treatments intended to address markets with significant unmet need (OTCID: WINT) 
- WindTree - New World Wind- Complete solution for the production of electricity, the Wind Tree is ideal for companies and communities. It reduces the carbon footprint of organizations by producing cleanly produced … 
- Windtree Therapeutics, Inc. (WINT) - Yahoo Finance- Find the latest Windtree Therapeutics, Inc. (WINT) stock quote, history, news and other vital information to help you with your stock trading and investing. 
- Windtree Therapeutics (WINT) Stock Price & Overview- 3 days ago · Get the latest Windtree Therapeutics, Inc. (WINT) stock price with financials, statistics, dividends, charts and more. 
- Windtree Therapeutics Announces Up To $520 Million in New- Jul 24, 2025 · Windtree Therapeutics, Inc. is a diversified company with several divisions, including a cryptocurrency treasury strategy and two promising therapeutic pipelines for which … 
- WINT Stock Price | Windtree Therapeutics Inc. Stock Quote (U.S.: …- 4 days ago · WINT | Complete Windtree Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. 
- Welcome | Windtree Therapeutics, Inc- Aug 5, 2021 · Using new scientific and clinical approaches, Windtree is developing a multi-asset franchise anchored around compounds with an ability to activate SERCA2a, with our lead … 
- Windtree Therapeutics (WINT) Stock Forecast & Price Target- Oct 24, 2025 · Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 05:53 AM ET. According to the research … 
- WINT: Windtree Therapeutics Inc - Stock Price, Quote and News - CNBC- Get Windtree Therapeutics Inc (WINT:OTCQB) real-time stock quotes, news, price and financial information from CNBC. 
- MANAGEMENT - WINDTREE THERAPEUTICS- Jed was appointed CEO of Windtree Therapeutics on December 1, 2024, and will continue to serve as a member of the Board which he has been a member of since October 2024. He has …